Artelo Biosciences, Inc.
ARTL
$7.16
-$0.15-2.05%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.88M | -12.49M | -10.50M | -9.72M | -9.83M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 208.00K | 137.00K | 54.00K | -- | -- |
| Total Other Non-Cash Items | 2.40M | 901.00K | 689.00K | 654.00K | 569.00K |
| Change in Net Operating Assets | 1.75M | 3.28M | 4.30M | 2.06M | 907.00K |
| Cash from Operations | -8.52M | -8.18M | -5.46M | -7.01M | -8.35M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -62.00K | 250.00K | 4.75M | 6.50M | 7.77M |
| Cash from Investing | -62.00K | 250.00K | 4.75M | 6.50M | 7.77M |
| Total Debt Issued | 608.00K | 737.00K | 737.00K | -- | -- |
| Total Debt Repaid | -24.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 6.28M | 4.58M | 1.14M | 57.00K | 112.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.87M | 5.32M | 1.87M | 57.00K | 112.00K |
| Foreign Exchange rate Adjustments | -23.00K | -28.00K | 18.00K | -1.00K | -8.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.74M | -2.64M | 1.19M | -449.00K | -477.00K |